19 studies found for:    pelvic floor disorders | NICHD [Lead]
Show Display Options
Download search resultsDownload the search results for:
pelvic floor disorders | NICHD [Lead] (19 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Behavioral Therapy Of Obstetric Sphincter Tears
Condition: Fecal Incontinence
Intervention:
2 Completed Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial
Condition: Pelvic Organ Prolapse
Interventions: Device: TVT;   Other: Sham
3 Recruiting Apical Suspension Repair for Vault Prolapse In a Three-Arm Randomized Trial Design
Condition: Visceral Prolapse
Interventions: Procedure: Open, Robotic, or Laparoscopic;   Procedure: Transvaginal Native Tissue Repair;   Procedure: Uphold™ LITE or Elevate™-AA
4 Completed Adaptive Behaviors Among Women With Bowel Incontinence: The ABBI Trial
Condition: Fecal Incontinence
Intervention:
5 Recruiting Combined Treatment for Mixed Incontinence
Conditions: Urinary Incontinence, Stress;   Urinary Incontinence, Urge
Interventions: Procedure: Miduretheral Sling;   Other: Miduretheral Sling with behavioral/pelvic floor therapy
6 Terminated Long-term Effectiveness of Abdominal Sacrocolpopexy for the Treatment of Pelvic Organ Prolapse
Conditions: Prolapse;   Urinary Incontinence
Intervention:
7 Completed Operations and Pelvic Muscle Training in the Management of Apical Support Loss: The OPTIMAL Trial
Condition: Pelvic Organ Prolapse
Interventions: Procedure: SSLF;   Procedure: ULS;   Behavioral: PMT
8 Active, not recruiting The Extended Operations And Pelvic Muscle Training In The Management Of Apical Support Loss Study
Condition: Pelvic Organ Prolapse
Interventions: Behavioral: Enrollment video;   Procedure: SSLF;   Procedure: ULS;   Behavioral: PMT;   Other: Usual Care
9 Completed ATLAS: Ambulatory Treatments for Leakage Associated With Stress
Conditions: Stress Urinary Incontinence;   Mixed Stress and Urge Urinary Incontinence
Interventions: Behavioral: Pelvic muscle training and exercises;   Device: Intravaginal incontinence pessary;   Device: Both pessary and pelvic muscle exercises
10 Completed Anticholinergic vs. Botox Comparison Study
Conditions: Urge Urinary Incontinence;   Overactive Bladder
Interventions: Drug: Botulinum toxin A (Botox A®);   Drug: Solifenacin 5mg;   Drug: Solifenacin 10mg;   Drug: Trospium chloride
11 Active, not recruiting Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA)
Condition: Refractory Urge Urinary Incontinence
Interventions: Device: InterStim® device;   Drug: Botox® injection
12 Active, not recruiting Study of Uterine Prolapse Procedures - Randomized Trial
Condition: Symptomatic Uterovaginal Prolapse at or Beyond the Hymen
Interventions: Procedure: Vaginal hysterectomy and uterosacral ligament suspension (USLS);   Procedure: Uphold® LITE
13 Active, not recruiting Controlling Anal Incontinence by Performing Anal Exercises With Biofeedback or Loperamide (CAPABLe)
Condition: Fecal Incontinence
Interventions: Drug: Loperamide;   Drug: Placebo;   Behavioral: Anal exercises with biofeedback;   Behavioral: Usual Care
14 Completed Pelvic Pain in Women With Endometriosis
Conditions: Endometriosis;   Pelvic Pain;   Healthy;   Tubal Ligation
Intervention:
15 Completed The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis
Conditions: Endometriosis;   Pelvic Pain
Intervention: Drug: Raloxifene
16 Completed Turner Syndrome: Genotype and Phenotype
Condition: Turner's Syndrome
Intervention:
17 Completed Adrenal Hyperplasia Among Young People With PCOS
Conditions: Adrenal Hyperplasia;   Polycystic Ovarian Syndrome;   Oligomenorrhea;   Obesity;   Hyperandrogenism
Intervention:
18 Completed Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist
Condition: Leiomyoma
Intervention: Drug: CDB-2914
19 Enrolling by invitation Natural History Study of Patients With Excess Androgen
Conditions: Congenital Adrenal Hyperplasia (CAH);   Familial Male-Limited Precocious Puberty (FMPP)
Intervention:

Indicates status has not been verified in more than two years